<DOC>
	<DOCNO>NCT02169739</DOCNO>
	<brief_summary>Previous study animal human show brief period reduce blood flow one organ tissue body help protect tissue subsequent injury cause reduced blood flow stroke . This phenomenon know remote ischemic preconditioning may help protect brain cell stroke . The investigator study specific stroke type call subcortical stroke common high rate recurrent stroke cognition problem despite intensive prevention measure .</brief_summary>
	<brief_title>Remote Preconditioning Over Time To Empower Cerebral Tissue</brief_title>
	<detailed_description>In study , investigator enroll 60 patient . All patient receive best standard medical therapy 2 year . In addition , investigator randomly assign 40 patient undergo daily active remote ischemic preconditioning 1 year , 20 patient 1 year standard medical therapy follow 1 year daily active remote ischemic preconditioning . Patient structure interview perform assess treatment well tolerate easy stroke patient use . Magnetic resonance ( MR ) picture brain used determine active treatment stop progression brain injury . Cognitive test wireless sensor technology measure use learn happen patient 's brain body active treatment .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Cerebral Small Vessel Diseases</mesh_term>
	<criteria>I . Clinical 1 . Clinical lacunar stroke syndrome within past 6 month 2 . Absence sign symptom cortical dysfunction 3 . No proximal large vessel atherosclerosis , intracranial atherosclerosis cerebellar stroke . 4 . No major cardioembolic source require anticoagulation specific therapy II . Imaging 1 . Magnetic Resonance Imaging ( MRI ) presence small subcortical ischemic , 1 : 1 . Diffusionweighted imaging ( DWI ) lesion &lt; 2.0cm size large dimension correspond clinical syndrome . 2 . Well delineated focal hyperintensity &lt; 2.0 cm size large dimension ( include rostrocaudal extent ) FLAIR T2 clearly correspond clinical syndrome . If focal hyperintensities present , case discuss principal investigator prior randomization 3 . Multiple ( least 2 ) hypointense lesion size 0.31.5 cm large dimension ( include rostrocaudal extent ) cerebral hemisphere FLAIR T1 patient whose qualify event clinically hemispheric 4 . Well delinated hypointense lesion &lt; 1.5 cm size large dimension ( include rostrocaudal extent ) FLAIR T1 correspond clinical syndrome . MRI must do least 1 month qualify stroke 2 . Absence cortical stroke large ( &gt; 1.5cm ) subcortical stroke , recent remote 3 . White matter hyperintensity score 2 ( moderate ) 3 ( severe ) European Scale AgeRelated White Matter Change 4 . Absence cerebral amyloid antipathy ( CAA ) per Boston Criteria . 1 . Disabling stroke ( Rankin Scale â‰¥4 ) 2 . Previous intracranial hemorrhage ( exclude traumatic ) hemorrhagic stroke 3 . Age 40 year 4 . High risk bleeding ( e.g . recurrent GI GU bleeding , active peptic ulcer disease , etc . ) 5 . Anticipated requirement long term use anticoagulant ( e.g . recurrent deep venous thrombosis ( DVT ) 6 . Prior cortical retinal stroke ( diagnose either clinically neuroimaging ) , prior cortical retinal transient ischemic attack ( TIA ) 7 . Prior ipsilateral carotid endarterectomy 8 . Impaired renal function : estimate GFR &lt; 40 9 . Intolerance contraindication aspirin clopidogrel ( include thrombocytopenia , prolong INR ) 10 . Mini Mental Status Exam score &lt; 24 ( adjust age education ) 11 . Medical contraindication MRI 12 . Pregnancy woman childbearing age follow effective method contraception 13 . Preexisting neurologic , psychiatric , advanced systemic disease would confound neurological functional outcome evaluation 14 . SBP &lt; 90 &gt; 200 15 . Known history limb vascular disease , limb vascular bypass surgery , limb deep venous thrombosis 16 . Prisoners 17 . Homeless individual 18 . Patient unable give inform consent available legally authorize representative provide inform consent 19 . Patient unlikely compliant therapy/ unwilling return follow visit 20 . Concurrent participation another study investigational drug device treatment 21 . Other likely specific cause stroke ( e.g . dissection , vasculitis , prothrombotic diathesis , drug abuse )</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>ischemic preconditioning</keyword>
	<keyword>remote ischemic preconditioning</keyword>
	<keyword>ischemic stroke</keyword>
	<keyword>white matter disease</keyword>
	<keyword>cerebral small vessel disease</keyword>
	<keyword>cognitive decline</keyword>
	<keyword>leukoaraiosis</keyword>
	<keyword>diffusion tensor image</keyword>
	<keyword>white matter hyper intensity score</keyword>
	<keyword>European scale age-related white matter change</keyword>
</DOC>